Ignite Creation Date:
2025-12-25 @ 1:45 AM
Ignite Modification Date:
2026-03-08 @ 1:05 AM
Study NCT ID:
NCT02748694
Status:
COMPLETED
Last Update Posted:
2021-03-19
First Post:
2016-04-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 1 TAK-041 First-in-Human Safety, Tolerability, and Pharmacokinetics Study
Sponsor:
Neurocrine Biosciences
Organization: